Evidence map›Paper›PMID 20606686›Full record

ReviewJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2010

MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.

Julie A Saugstad

Open access · bronzeAbstract readComparative StudyReview
In one paragraph

Review in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 224 citations in OpenAlex.

  1. Trial
  2. Trial
  3. The Role of Estrogen in Brain MicroRNAs Regulation.Advanced pharmaceutical bulletin · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD).International journal of molecular sciences · 2021
    Review
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Julie A SaugstadRobert Stone Dow Neurobiology Laboratories, Legacy Research, Portland, Oregon 97232, USA. jsaugstad@downeurobiology.org
Legacy Health · US

Funding

Neuroprotection by Novel Regulators of mGluR SignalingR01NS050221 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI SAUGSTAD, JULIE ANNE · 2006 to 2009
$1.2M
Role for MicroRNAs in Ischemic ToleranceR01NS064270 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI SAUGSTAD, JULIE ANNE · 2010 to 2012
$908k
Role of MicroRNAs in Ischemic ToleranceR21NS054220 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI SAUGSTAD, JULIE ANNE · 2006 to 2007
$378k
NINDS NIH HHS R01 NS050221NINDS NIH HHS R01NS050221NINDS NIH HHS R01 NS064270NINDS NIH HHS R21 NS054220NINDS NIH HHS R21NS054220
6 · The paper itself

Abstract

MicroRNAs are small RNAs that function as regulators of posttranscriptional gene expression. MicroRNAs are encoded by genes, and processed to form ribonucleoprotein complexes that bind to messenger RNA (mRNA) targets to repress translation or degrade mRNA transcripts. The microRNAs are particularly abundant in the brain where they serve as effectors of neuronal development and maintenance of the neuronal phenotype. They are also expressed in dendrites where they regulate spine structure and function as effectors in synaptic plasticity. MicroRNAs have been evaluated for their roles in brain ischemia, traumatic brain injury, and spinal cord injury, and in functional recovery after ischemia. They also serve as mediators in the brain's response to ischemic preconditioning that leads to endogenous neuroprotection. In addition, microRNAs are implicated in neurodegenerative disorders, including Alzheimer's, Huntington, Parkinson, and Prion disease. The discovery of microRNAs has expanded the potential for human diseases to arise from genetic mutations in microRNA genes or sequences within their target mRNAs. This review discusses microRNA discovery, biogenesis, mechanisms of gene regulation, their expression and function in the brain, and their roles in brain ischemia and injury, neuroprotection, and neurodegeneration.

Indexed as

AnimalsBrainBrain DiseasesBrain IschemiaHumansMicroRNAsNerve DegenerationNervous System DiseasesNeuronal PlasticityNeuroprotective AgentsRNA, MessengerMicroRNAsNeuroprotective AgentsRNA, Messenger

Identifiers

PMID20606686
PMCPMC2932764
OpenAlexW2009802273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.